Form 4: Precigen Director Converts RSUs to Common Stock

Precigen Director Cesar L. Alvarez converted 71,839 Restricted Stock Units into common stock on March 13, 2026, increasing his direct beneficial ownership.

Summary

• Cesar L. Alvarez, a Director of Precigen, Inc. (PGEN), acquired 71,839 shares of common stock.
• This acquisition resulted from the conversion of 71,839 Restricted Stock Units (RSUs).
• The RSUs vested in full on March 13, 2026.
• Following this transaction, Mr. Alvarez directly beneficially owns 782,909 shares of Precigen common stock.
• He now holds 0 derivative securities (RSUs) after the conversion.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a routine compensation event and a director maintaining direct ownership, indicating continued alignment with the company's performance.

Positives

• A director converting RSUs to common stock demonstrates continued direct ownership and alignment with shareholder interests.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly conversions of equity awards like RSUs, are common occurrences in publicly traded companies. While this specific filing doesn't reveal strategic shifts, it provides transparency into a director's direct equity holdings, which can be a signal of long-term commitment.

Comparison to Industry Standards

• This transaction is standard for equity compensation plans. Many biotech and life sciences companies, similar to Precigen, utilize RSUs as a key component of executive and director compensation to align interests with shareholders. There are no specific comparable companies or projects mentioned in this transactional filing.

Stakeholder Impact

• Shareholders: Increased transparency regarding director's direct equity holdings.

Key Dates

Recommendation

This Form 4 filing details a routine conversion of Restricted Stock Units by a director, which is an expected part of executive compensation. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The director's continued direct ownership is a neutral to slightly positive signal of alignment, but not a catalyst for a 'buy' or 'sell' decision.

Keywords

Precigen, PGEN, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Stock Ownership, Cesar L. Alvarez